A Single-Center Retrospective Cohort Analysis of Venetoclax in Relapsed/Refractory Multiple Myeloma

Despite recent advances, treatment of relapsed multiple myeloma (MM) remains a challenge. Pre-clinical studies suggest that bcl-2 inhibition can induce MM cell death and may synergize with bortezomib.

Source: Clinical Lymphoma, Myeloma and Leukemia - September 1, 2017 Category: Hematology Authors: Derek Galligan, Nina Shah, Jeffrey Wolf, Sandy Wong, Linda Abramovitz, Brenn Donnelly, Rupa Narayan, Gabriel Mannis, Shagun Arora, Amy Marsala, Miguel Cerejo, Thomas Martin Source Type: research